Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Melanoma Research|January 30, 2025
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockadeColin D Angell, Steven H Sun, Gabriella Lapurga, et al.
Oncoimmunology|June 23, 2017
Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptorElizabeth L McMichael, Nicholas B Courtney, Megan C Duggan, et al.
Breast Cancer Research and Treatment|September 9, 2021
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancerJasmine S Sukumar, Dionisia Quiroga, Mahmoud Kassem, et al.
Molecular Cancer Research : MCR|November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine KinaseHimanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
Therapeutic Advances in Medical Oncology|June 12, 2025
Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysisDionisia Quiroga, Charles Pei, Julie A Stephens, et al.
Breast Cancer Research and Treatment|July 4, 2025
Adverse events in patients treated with neoadjuvant chemo/immunotherapy for triple negative breast cancer: results from seven academic medical centersJessica Mezzanotte-Sharpe, Chih-Yuan Hsu, David Choi, et al.
Lymphatic Research and Biology|December 3, 2025
Using Group Concept Mapping to Define Priorities for Lymphedema Care and ResearchSara P Myers, Min-Jeong Cho, Erin E Burke, et al.
Oncology and Therapy|June 24, 2023
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast CancerKai Conrad Cecil Johnson, Daniel Goldstein, Jasmin Tharakan, et al.
BMC Cancer|May 21, 2020
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancerRobert Wesolowski, Andrew Stiff, Dionisia Quiroga, et al.
Therapeutic Advances in Medical Oncology|December 28, 2023
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancerNicole O Williams, Dionisia Quiroga, Courtney Johnson, et al.
Pageof 5